Haemonetics (HAE) Operating Expenses (2009 - 2026)

Haemonetics' Operating Expenses history runs 18 years deep, the most recent figure standing at $221.2 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 81.77% year-over-year to $221.2 million; the TTM figure through Mar 2026 stood at $630.9 million (up 19.67% YoY), while the FY2026 annual figure was $630.9 million, up 19.67% from the prior year.
• Operating Expenses was $221.2 million for Q1 2026 at Haemonetics, up from $135.0 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $221.2 million in Q1 2026 to a low of $102.9 million in Q1 2022.
• Historically, Operating Expenses has averaged $131.3 million across 5 years, with a median of $133.2 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Operating Expenses decreased 16.61% in 2025, then jumped 81.77% in 2026.
• A 5-year view of Operating Expenses shows it stood at $115.4 million in 2022, then rose by 14.26% to $131.9 million in 2023, then increased by 1.99% to $134.5 million in 2024, then gained by 0.35% to $135.0 million in 2025, then surged by 63.89% to $221.2 million in 2026.
• The last three Operating Expenses figures came in at $221.2 million (Q1 2026), $135.0 million (Q4 2025), and $136.3 million (Q3 2025), per Business Quant data.